274 related articles for article (PubMed ID: 9360524)
1. In familial hyperaldosteronism type I, hybrid gene-induced aldosterone production dominates that induced by wild-type genes.
Stowasser M; Gartside MG; Taylor WL; Tunny TJ; Gordon RD
J Clin Endocrinol Metab; 1997 Nov; 82(11):3670-6. PubMed ID: 9360524
[TBL] [Abstract][Full Text] [Related]
2. Severity of hypertension in familial hyperaldosteronism type I: relationship to gender and degree of biochemical disturbance.
Stowasser M; Bachmann AW; Huggard PR; Rossetti TR; Gordon RD
J Clin Endocrinol Metab; 2000 Jun; 85(6):2160-6. PubMed ID: 10852446
[TBL] [Abstract][Full Text] [Related]
3. Treatment of familial hyperaldosteronism type I: only partial suppression of adrenocorticotropin required to correct hypertension.
Stowasser M; Bachmann AW; Huggard PR; Rossetti TR; Gordon RD
J Clin Endocrinol Metab; 2000 Sep; 85(9):3313-8. PubMed ID: 10999827
[TBL] [Abstract][Full Text] [Related]
4. Evidence for persistent dysfunction of wild-type aldosterone synthase gene in glucocorticoid-treated familial hyperaldosteronism type I.
Stowasser M; Taylor WL; Gartside MG; Tunny TJ; Gordon RD
J Hypertens; 1997 Dec; 15(12 Pt 2):1729-33. PubMed ID: 9488230
[TBL] [Abstract][Full Text] [Related]
5. Biochemical evidence of aldosterone overproduction and abnormal regulation in normotensive individuals with familial hyperaldosteronism type I.
Stowasser M; Huggard PR; Rossetti TR; Bachmann AW; Gordon RD
J Clin Endocrinol Metab; 1999 Nov; 84(11):4031-6. PubMed ID: 10566645
[TBL] [Abstract][Full Text] [Related]
6. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.
Fardella CE; Mosso L; Gómez-Sánchez C; Cortés P; Soto J; Gómez L; Pinto M; Huete A; Oestreicher E; Foradori A; Montero J
J Clin Endocrinol Metab; 2000 May; 85(5):1863-7. PubMed ID: 10843166
[TBL] [Abstract][Full Text] [Related]
7. Familial hyperaldosteronism.
Stowasser M; Gordon RD
J Steroid Biochem Mol Biol; 2001 Sep; 78(3):215-29. PubMed ID: 11595502
[TBL] [Abstract][Full Text] [Related]
8. Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism.
Fallo F; Pilon C; Williams TA; Sonino N; Morra Di Cella S; Veglio F; De Iasio R; Montanari P; Mulatero P
J Hum Hypertens; 2004 Jan; 18(1):47-51. PubMed ID: 14688810
[TBL] [Abstract][Full Text] [Related]
9. Familial hyperaldosteronism type II: description of a large kindred and exclusion of the aldosterone synthase (CYP11B2) gene.
Torpy DJ; Gordon RD; Lin JP; Huggard PR; Taymans SE; Stowasser M; Chrousos GP; Stratakis CA
J Clin Endocrinol Metab; 1998 Sep; 83(9):3214-8. PubMed ID: 9745430
[TBL] [Abstract][Full Text] [Related]
10. Primary aldosteronism: learning from the study of familial varieties.
Stowasser M; Gordon RD
J Hypertens; 2000 Sep; 18(9):1165-76. PubMed ID: 10994747
[TBL] [Abstract][Full Text] [Related]
11. Aldosterone-producing adenomas do not contain glucocorticoid-remediable aldosteronism chimeric gene duplications.
Carroll J; Dluhy R; Fallo F; Pistorello M; Bradwin G; Gomez-Sanchez CE; Mortensen R
J Clin Endocrinol Metab; 1996 Dec; 81(12):4310-2. PubMed ID: 8954032
[TBL] [Abstract][Full Text] [Related]
12. Clinical, biochemical and genetic approaches to the detection of familial hyperaldosteronism type I.
Stowasser M; Bachmann AW; Jonsson JR; Tunny TJ; Klemm SA; Gordon RD
J Hypertens; 1995 Dec; 13(12 Pt 2):1610-3. PubMed ID: 8903619
[TBL] [Abstract][Full Text] [Related]
13. Familial hyperaldosteronism.
Torpy DJ; Stratakis CA; Chrousos GP
Braz J Med Biol Res; 2000 Oct; 33(10):1149-55. PubMed ID: 11004715
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid remediable aldosteronism: low morbidity and mortality in a four-generation italian pedigree.
Mulatero P; di Cella SM; Williams TA; Milan A; Mengozzi G; Chiandussi L; Gomez-Sanchez CE; Veglio F
J Clin Endocrinol Metab; 2002 Jul; 87(7):3187-91. PubMed ID: 12107222
[TBL] [Abstract][Full Text] [Related]
15. Frequency of familial hyperaldosteronism type 1 in a hypertensive pediatric population: clinical and biochemical presentation.
Aglony M; Martínez-Aguayo A; Carvajal CA; Campino C; García H; Bancalari R; Bolte L; Avalos C; Loureiro C; Trejo P; Brinkmann K; Giadrosich V; Mericq V; Rocha A; Avila A; Perez V; Inostroza A; Fardella CE
Hypertension; 2011 Jun; 57(6):1117-21. PubMed ID: 21502562
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of glucocorticoid-remediable aldosteronism in hypertensive children.
Kamrath C; Maser-Gluth C; Haag C; Schulze E
Horm Res Paediatr; 2011; 76(2):93-8. PubMed ID: 21625068
[TBL] [Abstract][Full Text] [Related]
17. Disorders of steroid 11 beta-hydroxylase isozymes.
White PC; Curnow KM; Pascoe L
Endocr Rev; 1994 Aug; 15(4):421-38. PubMed ID: 7988480
[TBL] [Abstract][Full Text] [Related]
18. Stress-induced Aldosterone Hyper-Secretion in a Substantial Subset of Patients With Essential Hypertension.
Markou A; Sertedaki A; Kaltsas G; Androulakis II; Marakaki C; Pappa T; Gouli A; Papanastasiou L; Fountoulakis S; Zacharoulis A; Karavidas A; Ragkou D; Charmandari E; Chrousos GP; Piaditis GP
J Clin Endocrinol Metab; 2015 Aug; 100(8):2857-64. PubMed ID: 25974737
[TBL] [Abstract][Full Text] [Related]
19. Genetic analysis of aldosterone synthase in patients with idiopathic hyperaldosteronism.
Takeda Y; Furukawa K; Inaba S; Miyamori I; Mabuchi H
J Clin Endocrinol Metab; 1999 May; 84(5):1633-7. PubMed ID: 10323392
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid-suppressible hyperaldosteronism and adrenal tumors occurring in a single French pedigree.
Pascoe L; Jeunemaitre X; Lebrethon MC; Curnow KM; Gomez-Sanchez CE; Gasc JM; Saez JM; Corvol P
J Clin Invest; 1995 Nov; 96(5):2236-46. PubMed ID: 7593610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
